TruScan RM - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

TruScan RM


Thermo Scientific portable solutions deliver specialized identification and analysis of raw materials for the highly regulated global pharmaceutical industry.

With greater than 650 GMP facility installations worldwide, we’ve successfully implemented our solutions into the top pharmaceutical companies and regulatory enforcement agencies worldwide – enabling them to increase productivity and realize a rapid return on their investment.

We are more than the leading provider of portable analytical instruments. We are a true partner, delivering expertise and solutions to improve processes, reduce risk & costs, and achieve competitive advantage.

Developed with in-depth pharmaceutical industry experience, Thermo Scientific handheld analyzers provide manufacturers with a portable solution to achieve quality initiatives throughout the manufacturing process.
The Thermo Scientific TruScan RM, based on Raman spectroscopy, and the Thermo Scientific microPHAZIR RX, based on Near-Infrared spectroscopy, are simple to use and enable on-the-spot, actionable Pass-Fail results within seconds.
 
Both analyzers are 21 CFR part 11 compliant and meet the requirements of global pharmacopeias.  Our handheld solutions are used by 24 of the top 25 global pharmaceutical manufacturers, driving significant time and cost savings. 

Thermo Scientific is part of Thermo Fisher Scientific, the world leader in serving science.

 

Thermo Scientific – Portable Analytical Instruments

Website: www.thermoscientific.com/quality

E-mail: sales.chemid@thermofisher.com

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
27%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns

Click here